The ELOVL5 gene helps your body make certain long-chain fats, including omega-3 and omega-6 fats, that support the brain, nerves, and retina. The protein made by this gene helps your cells build these fats so nerve signaling and cell membranes work well. If the gene does not work properly, people may develop problems with balance and coordination, often called spinocerebellar ataxia type 38, and some also notice speech, vision, or hearing changes. ELOVL5 is mainly known in medical genetics rather than popular culture.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes contain the directions for building proteins, which are the working parts of cells. Other genes mainly help determine when certain processes happen, where they happen, and how strongly they occur. Taken together, genes influence the body’s development and function, and they can shape how you respond to food, stress, or medications. For a more detailed look at this topic, you can learn more in the LearnHub.
Overview
ELOVL5Gene function
What if the gene works
The ELOVL5 gene helps cells make longer omega-3 and omega-6 fats. These fats support cell membranes and are especially important for healthy brain, nerve, and eye function.
Risk
What if the gene does not work
Variants in the ELOVL5 gene are best known for causing spinocerebellar ataxia type 38, with gradually worsening balance and coordination problems. Milder and more severe variants can influence when symptoms begin and whether eye movement, smell, or hearing changes appear.
Treatment
What does that mean for your treatment
No ELOVL5-specific treatment or drug selection approach is currently established in clinical guidelines. The ELOVL5 gene is being studied in inherited ataxia research because altered handling of certain fats may influence symptoms.
Conditions associated with ELOVL5
Gene function
What if the gene works
Across the body, cells make some fats longer before they can be used well. The ELOVL5 gene provides instructions for a key step in handling polyunsaturated fats (fats used in cell membranes and cell signals). In practical terms, ELOVL5 gene function in fatty acid metabolism helps support cell membranes and normal cell communication.
The ELOVL5 gene helps cells extend certain polyunsaturated fats by adding two carbon units at a time. This turns shorter fat building blocks into longer forms your body can use.
Many cells need long-chain fats to build membranes that stay flexible and work smoothly. By supplying these fats, the ELOVL5 gene supports everyday cell structure and routine cell activity.
Some longer fats made through ELOVL5 become starting material for lipid signals, which are fat-based chemical messages between cells. This helps tissues keep a steady supply of important signaling ingredients.
What is a variant?
In a gene, a genetic variant is a small change in the DNA sequence. These changes are common and help account for normal differences among people, such as appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. Sometimes, however, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ELOVL5 gene can alter the protein’s shape, stability, or location inside the cell, which may reduce its fatty acid elongation activity. Some changes leave partial function, while more disruptive variants can sharply lower activity or interfere with how the protein interacts with cell membranes. This pattern helps explain how ELOVL5 gene variants affect the protein and why, in ELOVL5 related ataxia, symptoms can vary in age of onset and severity.
How variants are linked to conditions
Pathogenic variants in the ELOVL5 gene cause spinocerebellar ataxia type 38, so an ELOVL5 gene variant is most clearly linked to this inherited neurologic condition. People with this diagnosis often develop slowly progressive problems with balance and coordination in midlife, and some also notice speech changes, involuntary movements, or a reduced sense of smell. This is a rare monogenic condition, so a disease-causing ELOVL5 variant can confirm the diagnosis in the right clinical setting.
A variant is not necessarily a diagnosis
Genetic variants are a normal feature of human biology and are common across the general population. Most do not have a direct effect on health and simply represent natural variation among people. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors play a role. In some cases, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For harmful changes in the ELOVL5 gene, risk is mainly linked to whether the variant was inherited, and there is not yet broadly confirmed evidence that specific lifestyle or environmental factors clearly increase or reduce that risk. Anyone concerned about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of ELOVL5 variants
ELOVL5-related conditions that are clearly established in human genetics follow an autosomal dominant inheritance pattern, which means one changed copy of the ELOVL5 gene can be enough to cause the condition. In practical terms, a parent with an ELOVL5 gene variant has a 50% chance of passing it to each child. This is the key point in understanding how ELOVL5 gene variants are inherited in families. Men and women can inherit and pass on the variant equally.
What does my ELOVL5 result mean for my family?
A harmful change in the ELOVL5 gene is linked to a condition that usually runs in families in a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same change. For many families, this means first-degree relatives may want to learn whether the result applies to them too. Family members who carry the change can be affected in different ways, even within the same family.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for variants in the ELOVL5 gene usually uses a blood or saliva sample. A lab reads the gene’s DNA code, often as part of an ataxia panel or a broader sequencing test, to look for changes that may help confirm an inherited cause of symptoms and show whether a variant runs in a family.
When should I consider getting a genetic test?
Genetic testing for the ELOVL5 gene may be worth considering if there is a family history of an inherited balance and coordination condition, or if someone has ongoing problems with walking, balance, speech, or tremor that suggest this kind of condition. A result can help clarify whether ELOVL5 is the cause.
A genetic result is only one part of your health story
Genetic findings can be informative, although how much they reveal varies based on the condition and the type of variant involved. Over time, factors such as lifestyle, environment, age, and medical history also shape how the body functions. For some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body handles medicines, so the same treatment may work well for one person but less well for another. Small differences in genes can change how quickly a drug is absorbed, broken down, or moved through the body, and this can influence how much benefit you get as well as how sensitive you are to side effects. This kind of variation is common and is one reason medication response can differ from person to person.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medications. It focuses on the links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. Understanding this can support more informed and more individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the ELOVL5 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so questions about side effects, new symptoms, or how well a treatment is working are best discussed with your doctor.
History
The ELOVL5 gene entered medical research through work on how the body makes long chain fats that support the brain, eyes, and other tissues. In the early 2000s, researchers identified ELOVL5 as one of the human elongase genes, a group involved in lengthening fatty acids. Building on this early work, scientists later connected variants in the ELOVL5 gene with an inherited balance and coordination condition called spinocerebellar ataxia type 38. That discovery helped link changes in fatty acid handling to specific neurologic symptoms seen in some families. Over time, descriptions became more precise, and ELOVL5 gained a clearer place in both metabolism research and inherited neurology.